UOC
IBB icon

UBS O'Connor’s iShares Biotechnology ETF IBB Stock Holding History

UBS O'Connor’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,000
Closed -$4.71M – 979
2022
Q2 		$4.71M Buy
40,000
+15,000
+60% +$1.78M 0.05% 341
2022
Q1 		$3.26M Buy
+25,000
New +$3.26M 0.04% 411
2016
Q2 		– Sell
-114,777
Closed -$9.98M – 453
2016
Q1 		$9.98M Buy
+114,777
New +$10.3M 0.1% 203

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS O'Connor's IBB Position: Q3 2022 in Review

UBS O'Connor sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 40,000 shares — an estimated $4.71M sold.

UBS O'Connor first reported a position in IBB in Q1 2016 and held it in 3 quarters. The position peaked at $9.98M in Q1 2016. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • UBS O'Connor reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
  • UBS O'Connor sold 40,000 iShares Biotechnology ETF shares in Q3 2022, an estimated $4.71M.
  • UBS O'Connor first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 3 quarters.
  • UBS O'Connor's iShares Biotechnology ETF position peaked at $9.98M in Q1 2016.
  • 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.